Fever-Tree
Discussed in 1 interview.
Interviews
-
Fall 2025
Andrew Rosenblum
Bonsai Partners
Andrew went from short selling to studying 100-baggers. He explains his idea of barriers to investment and why he likes Fever-Tree after the Molson Coors deal.
Quality compoundersBuilding a firm